Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy

Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy

Abstract Chimeric antigen receptor (CAR) T cells have been successfully used in adoptive cell therapy for malignancies. However, some obstacles, including side effects such as graft‐versus‐host disease and cytokine release syndrome, therapy resistance, limited sources, as well as high cost, limited...

Full description

Bibliographic Details
Main Authors: Yan Wang, Shengjie Jin, Qiqi Zhuang, Na Liu, Ruyi Chen, Sofia Abdulkadir Adam, Jie Jin, Jie Sun
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:MedComm
Subjects:
cancer
chimeric antigen receptor
hematologic malignancies
immunotherapy
leukemia
NK cell
Online Access:https://doi.org/10.1002/mco2.422

Internet

https://doi.org/10.1002/mco2.422

Similar Items